Recordati Industria Chimica e Farmaceutica S.p.A. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was EUR 419.38 million compared to EUR 384.84 million a year ago. Net income was EUR 96.72 million compared to EUR 89.87 million a year ago. Basic earnings per share from continuing operations was EUR 0.47 compared to EUR 0.436 a year ago. Diluted earnings per share from continuing operations was EUR 0.462 compared to EUR 0.43 a year ago.